- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT02408718
Assistive Device Training in Multiple Sclerosis (ADT)
Assistive Device Training for Functional Mobility and Connectivity in Multiple Sclerosis
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
40 people with Multiple Sclerosis, who routinely use ambulatory assistive devices and have fallen at least once in the past year, will be randomized into two groups. One group will receive a 6-week training program in the use of their assistive device; the other group will be wait-listed, and may choose to receive the training after their participation in the study is completed. All participants will receive mobility assessments at baseline, 6-8 weeks later, and 3 months after that. All participants will record their falls on falls calendars. Participants in the training group will receive MRI scans to assess neural connectivity at baseline and after completion of the training program.
The purpose of the study is to determine whether participation in the training program reduces falls and increases functional mobility when compared to the wait-listed group, and also to determine whether any change in neural connectivity, as assessed by MRI scans, is seen in those who participate in the training.
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
Oregon
-
Portland, Oregon, États-Unis, 97239
- VA Portland Health Care System
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Multiple Sclerosis of any type,
- self-reported history of at least 1 fall in the previous year,
- able to walk at least 25 feet with or without an assistive device,
- clinically stable Multiple Sclerosis (no relapse in 30 days prior to enrollment),
- intermittent or constant unilateral or bilateral assistance required to walk,
- right-handed, willingness to remain consistent with medication use and level of physical activity for the duration of the study.
Exclusion Criteria:
- serious psychiatric or medical conditions that would preclude reliable participation in the study,
- dementia (MMSE <24),
- deafness,
- blindness,
- inability to follow directions in English,
- significant upper extremity tremor or weakness,
- more than 1 hour of assistive device training within the previous 3 years,
- any exclusions to receiving MRI scans (implanted devices, anxiety, claustrophobia, body weight over 350 lbs).
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Soins de soutien
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Comparateur actif: Training group
Subjects randomized to this group will receive a 6 week Assistive Device Training program in the use of their assistive device.
They will have mobility assessments taken at baseline, after the training program has been completed, and 3 months later.
During this time, their falls will be recorded monthly using prospective falls calendars.
Members of this group will also receive MRI scans at baseline and after the completion of the training program.
|
Six-week training program on the proper use of the subject's assistive device (eg.
cane, walker, etc).
|
|
Aucune intervention: Wait-list control
Subjects in this group will participate in the same mobility assessments and completion of the falls calendars, but will receive no intervention during this time.
These subjects will have the opportunity to receive the training sessions when all assessment visits have been completed.
These subjects will not receive MRI scans.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change from Baseline in Functional Mobility at Completion of Training and the Following Three Months
Délai: At baseline, 1 week after completion of training, 3 months later
|
Timed Up and Go test, Timed 25-Foot Walk, 2 minute timed walk), Multiple Sclerosis Walking Scale-12
|
At baseline, 1 week after completion of training, 3 months later
|
|
Change from Baseline in Falls at Completion of Training and the Following Three Months
Délai: First week of training, last week of training, 3 months later
|
Change in rate of falls between time frames
|
First week of training, last week of training, 3 months later
|
|
Change from Baseline in Functional Neural Connectivity (fMRI) at Completion of Training
Délai: At baseline, 1 week after completion of training
|
Resting-state (task free) functional Magnetic Resonance Imaging (fcMRI)
|
At baseline, 1 week after completion of training
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change from Baseline in Satisfaction with Assistive Device at Completion of Training and the Following Three Months
Délai: At baseline, 1 week after completion of training, 3 months later
|
Quebec User Evaluation of Satisfaction with Assistive Technologies
|
At baseline, 1 week after completion of training, 3 months later
|
|
Change from Baseline in Balance Confidence at Completion of Training and the Following Three Months
Délai: At baseline, 1 week after completion of training, 3 months later
|
Activities-specific Balance Confidence Questionnaire
|
At baseline, 1 week after completion of training, 3 months later
|
|
Change from Baseline in Multiple Sclerosis Impact at Completion of Training and the Following Three Months
Délai: At baseline, 1 week after completion of training, 3 months later
|
Multiple Sclerosis Impact Scale-29
|
At baseline, 1 week after completion of training, 3 months later
|
|
Change from Baseline in Physical Activity at Completion of Training and the Following Three Months
Délai: At baseline, 1 week after completion of training, 3 months later
|
International Physical Activity Questionnaire
|
At baseline, 1 week after completion of training, 3 months later
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Les enquêteurs
- Chercheur principal: Michelle H. Cameron, MD, PT MCR, Portland VA Medical Center
Publications et liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Estimation)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 3559
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur Assistive Device Training
-
Università degli Studi di SassariComplétéSclérose en plaques | Fatigue | FaiblesseItalie
-
Universidad Complutense de MadridComplété
-
Cairo UniversityRecrutementSyndrome chronique du COVID-19Egypte
-
Ebru TekinComplétéFormation neuroathlétique | Joueurs de Football Américain | Formation RéactiveTurquie (Türkiye)
-
University of ValenciaComplétéMaladie neuro-dégénérativeEspagne
-
Ankara Etlik City HospitalRecrutementArthrose du genou | Entraînement à l'équilibre | Rééducation postopératoire | Récupération totale d'arthroplastie du genouTurquie
-
Cairo UniversityComplété
-
Changhua Christian HospitalRecrutementAccident vasculaire cérébral | Réadaptation de la marche après un AVCTaïwan
-
Brno University HospitalActif, ne recrute pas
-
Queen's UniversityComplétéLes troubles mentauxCanada